Khurram Jamil, MD
Sharpshooter · DISC type CDDr. Khurram Jamil is the Chief Medical Officer at Galectin Therapeutics, focusing on hepatology drug development. Described by colleagues as brilliant and dedicated, he has guided therapies through FDA approval and holds patents for treating liver disease. He earned his MD from Seton Hall University.
Beyond his clinical expertise, Khurram invests in professional growth, having completed executive education at Kellogg and NYU Stern. He holds certifications in coaching and decision-making, indicating a strong interest in leadership development and the business side of the pharmaceutical industry.
He holds a U. S. patent for a method of treating a specific subset of patients suffering from Hepatorenal Syndrome.
Read the full overview →How Khurram shows up
They respond better to strong and respectful interactions. They like to move fast and expect the same from others. They are not always relationship oriented.
Topics Khurram cares about
Work history
Media appearances
DISC profile (public)
Calculativeness (C)
Calculativeness (C) reflects the degree to which a person is likely to be cautious, systematic and analytical. Those scoring high tend to emphasise quality and accuracy.
More profiles
Discover additional public profiles from our index.
Search more profiles
Looking for someone else? Search here for anyone.